Loading company…
Amsterdam-based developer of ophthalmic products for dry eye and glaucoma, including TREHAPAN and VisuXL Gel.
Founded in 2016 in Amsterdam, Netherlands, VISUfarma B.V. develops and markets ophthalmic products for eye health and conditions such as Dry Eye Syndrome and glaucoma. Its flagship TREHAPAN provides long-lasting protection for patients with dry eye, and VisuXL Gel serves those with more severe symptoms. The company is led by CEO Fabrizio Giombini and was founded by Thomas Van Haarlem. It sells B2B to eye care specialists, pharmacies and hospitals in Europe and North America, and is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in